CCR5 intrabody-enfuvirtide derivative conjugate (Roche)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCCR5 intrabody-enfuvirtide derivative conjugate (Roche)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionC-C chemokine receptor type 5 modulators

TargetsC-C chemokine receptor type 5

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesRoche Holding Ag

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRoche Holding Ag

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A